Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleFirst proteasome inhibitor approved for multiple myeloma.AuthorsTwombly, ReneeAbstractReports on the approval of the proteasome inhibitor Velcade for use in treating multiple myeloma. Focus of therapeutic mechanism; Effectiveness in cell growth regulation and metabolism'; Transcription and secretion of cytokine factors.SubjectsPROTEASE inhibitors; MULTIPLE myeloma treatmentPublicationJNCI: Journal of the National Cancer Institute, 2003, Vol 95, Issue 12, p845ISSN0027-8874Publication typejournal articleDOI10.1093/jnci/95.12.845